Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 121

1.

Recovery and prognostic value of myocardial strain in ST-segment elevation myocardial infarction patients with a concurrent chronic total occlusion.

Elias J, van Dongen IM, Hoebers LP, Ouweneel DM, Claessen BEPM, Råmunddal T, Laanmets P, Eriksen E, Piek JJ, van der Schaaf RJ, Ioanes D, Nijveldt R, Tijssen JG, Henriques JPS, Hirsch A; EXPLORE investigators.

Eur Radiol. 2019 Jul 26. doi: 10.1007/s00330-019-06338-x. [Epub ahead of print]

PMID:
31350585
2.

Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trials.

Guedeney P, Giustino G, Sorrentino S, Claessen BE, Camaj A, Kalkman DN, Vogel B, Sartori S, De Rosa S, Baber U, Indolfi C, Montalescot G, Dangas GD, Rosenson RS, Pocock SJ, Mehran R.

Eur Heart J. 2019 Jul 3. pii: ehz430. doi: 10.1093/eurheartj/ehz430. [Epub ahead of print]

PMID:
31270529
3.

ST-segment elevation myocardial infarction.

Vogel B, Claessen BE, Arnold SV, Chan D, Cohen DJ, Giannitsis E, Gibson CM, Goto S, Katus HA, Kerneis M, Kimura T, Kunadian V, Pinto DS, Shiomi H, Spertus JA, Steg PG, Mehran R.

Nat Rev Dis Primers. 2019 Jun 6;5(1):39. doi: 10.1038/s41572-019-0090-3. Review.

PMID:
31171787
4.

Dual-Antiplatelet Therapy Cessation and Cardiovascular Risk in Relation to Age: Analysis From the PARIS Registry.

Joyce LC, Baber U, Claessen BE, Sartori S, Chandrasekhar J, Cohen DJ, Henry TD, Ariti C, Dangas G, Faggioni M, Aoi S, Gibson CM, Aquino M, Krucoff MW, Vogel B, Moliterno DJ, Sorrentino S, Colombo A, Chieffo A, Kini A, Guedeney P, Witzenbichler B, Weisz G, Steg PG, Pocock S, Mehran R.

JACC Cardiovasc Interv. 2019 May 27;12(10):983-992. doi: 10.1016/j.jcin.2019.02.033.

PMID:
31122354
5.

Impact of percutaneous closure device type on vascular and bleeding complications after TAVR: A post hoc analysis from the BRAVO-3 randomized trial.

Power D, Schäfer U, Guedeney P, Claessen BE, Sartori S, Sorrentino S, Lefèvre T, Kupatt C, Tchetche D, Dumonteil N, Webb JG, Colombo A, Windecker S, Ten Berg JM, Hildick-Smith D, Boekstegers P, Linke A, Tron C, Van Belle E, Asgar AW, Jeger R, Sardella G, Hink U, Husser O, Grube E, Lechthaler I, Wijngaard P, Anthopoulos P, Deliargyris EN, Bernstein D, Hengstenberg C, Mehran R, Dangas GD.

Catheter Cardiovasc Interv. 2019 Jun 1;93(7):1374-1381. doi: 10.1002/ccd.28295. Epub 2019 May 22.

PMID:
31116908
6.

Residual Inflammatory Risk in Patients With Low LDL Cholesterol Levels Undergoing Percutaneous Coronary Intervention.

Guedeney P, Claessen BE, Kalkman DN, Aquino M, Sorrentino S, Giustino G, Farhan S, Vogel B, Sartori S, Montalescot G, Sweeny J, Kovacic JC, Krishnan P, Barman N, Dangas G, Kini A, Baber U, Sharma S, Mehran R.

J Am Coll Cardiol. 2019 May 21;73(19):2401-2409. doi: 10.1016/j.jacc.2019.01.077. Erratum in: J Am Coll Cardiol. 2019 Jul 23;74(3):481-482.

PMID:
31097159
7.

Outcomes by Gender and Ethnicity After Percutaneous Coronary Intervention.

Mahajan AM, Claessen BE, Chandrasekhar J, Sartori S, Aquino M, Baber U, Dangas G, Kovacic JC, Krishnan P, Moreno P, Sweeny J, Barman N, Vijay P, Kini A, Mehran R, Sharma S.

Am J Cardiol. 2019 Jun 15;123(12):1941-1948. doi: 10.1016/j.amjcard.2019.03.019. Epub 2019 Mar 19.

PMID:
31005238
8.

Influence of Baseline Anemia on Dual Antiplatelet Therapy Cessation and Risk of Adverse Events After Percutaneous Coronary Intervention.

Faggioni M, Baber U, Sartori S, Chandrasekhar J, Cohen DJ, Henry TD, Claessen BE, Dangas GD, Gibson CM, Krucoff MW, Vogel B, Moliterno DJ, Sorrentino S, Colombo A, Chieffo A, Kini A, Farhan S, Ariti C, Witzenbichler B, Weisz G, Steg PG, Pocock S, Mehran R.

Circ Cardiovasc Interv. 2019 Apr;12(4):e007133. doi: 10.1161/CIRCINTERVENTIONS.118.007133.

PMID:
30998384
9.

Effect of stent diameter in women undergoing percutaneous coronary intervention with early- and new-generation drug-eluting stents: From the WIN-DES collaboration.

Camaj A, Giustino G, Claessen BE, Baber U, Power DA, Sartori S, Aquino M, Stone GW, Windecker S, Dangas G, Mehran R.

Int J Cardiol. 2019 Jul 15;287:59-61. doi: 10.1016/j.ijcard.2019.03.034. Epub 2019 Mar 19.

PMID:
30982549
10.

Exercise testing after chronic total coronary occlusion revascularization in patients with STEMI and a concurrent CTO: A subanalysis of the EXPLORE-trial.

van Veelen A, van Dongen IM, Elias J, Råmunddal T, Eriksen E, van der Schaaf RJ, Claessen BEPM, Postema PG, Henriques JPS.

Catheter Cardiovasc Interv. 2019 Apr 9. doi: 10.1002/ccd.28282. [Epub ahead of print]

PMID:
30968546
11.

Temporal Trends in Statin Prescriptions and Residual Cholesterol Risk in Patients With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention.

Guedeney P, Claessen BE, Baber U, Camaj A, Sorrentino S, Aquino M, Blum M, Chandiramani R, Goel R, Elsayed S, Kovacic JC, Sweeny J, Barman N, Moreno P, Dangas GD, Kini A, Sharma S, Mehran R.

Am J Cardiol. 2019 Jun 1;123(11):1788-1795. doi: 10.1016/j.amjcard.2019.03.005. Epub 2019 Mar 9.

PMID:
30955866
12.

Associations between use of prasugrel vs clopidogrel and outcomes by type of acute coronary syndrome: an analysis from the PROMETHEUS registry.

Ge Z, Baber U, Claessen BE, Chandrasekhar J, Chandiramani R, Li SX, Sartori S, Kini AS, Rao SV, Weiss S, Henry TD, Kapadia S, Muhlestein B, Strauss C, Toma C, DeFranco A, Effron MB, Keller S, Baker BA, Pocock S, Dangas G, Mehran R.

J Thromb Thrombolysis. 2019 Jul;48(1):42-51. doi: 10.1007/s11239-019-01842-9.

PMID:
30924052
13.

Hope for the best, prepare for the worst: How to manage coronary perforations.

Claessen BE, Mehran R.

Catheter Cardiovasc Interv. 2019 Mar 1;93(4):E255-E256. doi: 10.1002/ccd.28055.

PMID:
30859726
14.

Cardiology fellows-in-training are exposed to relatively high levels of radiation in the cath lab compared with staff interventional cardiologists-insights from the RECAP trial.

Vlastra W, Claessen BE, Beijk MA, Sjauw KD, Streekstra GJ, Wykrzykowska JJ, Vis MM, Koch KT, de Winter RJ, Piek JJ, Henriques JPS, Delewi R.

Neth Heart J. 2019 Jun;27(6):330-333. doi: 10.1007/s12471-019-1254-1.

15.

Leave nothing behind: Promising results for coronary drug-coated balloons in clinical practice.

Claessen BE, Dangas GD.

Catheter Cardiovasc Interv. 2019 Feb 1;93(2):189-190. doi: 10.1002/ccd.28085.

PMID:
30719858
16.

Small-vessel PCI outcomes in men, women, and minorities following platinum chromium everolimus-eluting stents: Insights from the pooled PLATINUM Diversity and PROMUS Element Plus Post-Approval studies.

Guedeney P, Claessen BE, Mehran R, Kandzari DE, Aquino M, Davis S, Tamis L, Wang JC, Othman I, Gigliotti OS, Haghighat A, Singh S, Lopez M, Giugliano G, Horwitz PA, Sorrentino S, Underwood P, Allocco D, Meredith IT, Batchelor W.

Catheter Cardiovasc Interv. 2019 Jul 1;94(1):82-90. doi: 10.1002/ccd.28071. Epub 2019 Jan 21.

PMID:
30666784
17.

Value of the SYNTAX Score in ST-Elevation Myocardial Infarction Patients With a Concomitant Chronic Total Coronary Occlusion(from the EXPLORE Trial).

van Dongen IM, Elias J, García-García HM, Hoebers LP, Ouweneel DM, Scheunhage EM, Delewi R, Råmunddal T, Eriksen E, Claessen BE, van der Schaaf RJ, Henriques JPS; EXPLORE investigators.

Am J Cardiol. 2019 Apr 1;123(7):1035-1043. doi: 10.1016/j.amjcard.2018.12.028. Epub 2019 Jan 4.

18.

Antithrombotic Therapy After Transcatheter Aortic Valve Replacement.

Guedeney P, Mehran R, Collet JP, Claessen BE, Ten Berg J, Dangas GD.

Circ Cardiovasc Interv. 2019 Jan;12(1):e007411. doi: 10.1161/CIRCINTERVENTIONS.118.007411.

PMID:
30630354
19.

Incidence, predictors, and outcomes of DAPT disruption due to non-compliance vs. bleeding after PCI: insights from the PARIS Registry.

Moalem K, Baber U, Chandrasekhar J, Claessen BE, Sartori S, Aquino M, Dangas G, Iakovou I, Colombo A, Kini A, Gibson M, Krucoff M, Chieffo A, Moliterno D, Witzenbichler B, Pocock S, Mehran R.

Clin Res Cardiol. 2019 Jun;108(6):643-650. doi: 10.1007/s00392-018-1392-2. Epub 2019 Jan 3.

PMID:
30607496
20.

Go With the Flow When Instantaneous Wave-Free Ratio-Fractional Flow Reserve Discordance Occurs: Indeed, Beware When Relying on Fractional Flow Reserve Alone.

Stegehuis VE, van de Hoef TP, Piek JJ, Claessen BE.

JACC Cardiovasc Interv. 2018 Dec 10;11(23):2435-2436. doi: 10.1016/j.jcin.2018.09.026. No abstract available.

PMID:
30522677
21.

Impact of coronary artery disease and percutaneous coronary intervention in women undergoing transcatheter aortic valve replacement: From the WIN-TAVI registry.

Guedeney P, Tchétché D, Petronio AS, Mehilli J, Sartori S, Lefèvre T, Presbitero P, Capranzano P, Iadanza A, Sardella G, Van Mieghem NM, Sorrentino S, Claessen BEPM, Chandrasekhar J, Vogel B, Kalkman DN, Meliga E, Dumonteil N, Fraccaro C, Trabattoni D, Mikhail G, Ferrer-Grazia MC, Naber C, Kievit P, Baber U, Sharma S, Morice MC, Chieffo A, Mehran R; WIN TAVI Investigators.

Catheter Cardiovasc Interv. 2019 May 1;93(6):1124-1131. doi: 10.1002/ccd.28012. Epub 2018 Dec 4.

PMID:
30511802
22.

Use of prasugrel vs clopidogrel and outcomes in patients with and without diabetes mellitus presenting with acute coronary syndrome undergoing percutaneous coronary intervention.

Faggioni M, Baber U, Chandrasekhar J, Sartori S, Claessen BE, Rao SV, Vogel B, Effron MB, Poddar K, Farhan S, Kini A, Weintraub W, Toma C, Sorrentino S, Weiss S, Snyder C, Muhlestein JB, Kapadia S, Keller S, Strauss C, Aquino M, Baker B, Defranco A, Pocock S, Henry T, Mehran R.

Int J Cardiol. 2019 Jan 15;275:31-35. doi: 10.1016/j.ijcard.2018.10.071. Epub 2018 Oct 25.

PMID:
30391067
23.

Paravalvular Leak: An Interesting Interplay of Acquired vWF-Disease and Late Bleeding After TAVR.

Mehran R, Sorrentino S, Claessen BE.

J Am Coll Cardiol. 2018 Oct 30;72(18):2149-2151. doi: 10.1016/j.jacc.2018.09.005. No abstract available.

PMID:
30360824
24.

Residual inflammatory risk and the impact on clinical outcomes in patients after percutaneous coronary interventions.

Kalkman DN, Aquino M, Claessen BE, Baber U, Guedeney P, Sorrentino S, Vogel B, de Winter RJ, Sweeny J, Kovacic JC, Shah S, Vijay P, Barman N, Kini A, Sharma S, Dangas GD, Mehran R.

Eur Heart J. 2018 Dec 7;39(46):4101-4108. doi: 10.1093/eurheartj/ehy633.

PMID:
30358832
25.

The prevalence, predictors and outcomes of guideline-directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry.

Ge Z, Baber U, Claessen BE, Farhan S, Chandrasekhar J, Li SX, Sartori S, Kini AS, Rao SV, Weiss S, Henry TD, Vogel B, Sorrentino S, Faggioni M, Kapadia S, Muhlestein B, Strauss C, Toma C, DeFranco A, Effron MB, Keller S, Baker BA, Pocock S, Dangas G, Mehran R.

Catheter Cardiovasc Interv. 2019 Feb 15;93(3):E112-E119. doi: 10.1002/ccd.27860. Epub 2018 Oct 23.

PMID:
30351514
26.

Assessing and minimizing the risk of percutaneous coronary intervention in patients with chronic kidney disease.

Guedeney P, Sorrentino S, Vogel B, Baber U, Claessen BE, Mehran R.

Expert Rev Cardiovasc Ther. 2018 Nov;16(11):825-835. doi: 10.1080/14779072.2018.1526082. Epub 2018 Oct 16. Review.

PMID:
30324814
27.

Impact of Baseline Atrial Fibrillation on Outcomes Among Women Who Underwent Contemporary Transcatheter Aortic Valve Implantation (from the Win-TAVI Registry).

Guedeney P, Chieffo A, Snyder C, Mehilli J, Petronio AS, Claessen BE, Sartori S, Lefèvre T, Presbitero P, Capranzano P, Tchétché D, Iadanza A, Sardella G, Van Mieghem NM, Chandrasekhar J, Vogel B, Sorrentino S, Kalkman DN, Meliga E, Dumonteil N, Fraccaro C, Trabattoni D, Mikhail G, Ferrer MC, Naber C, Kievit P, Baber U, Sharma S, Morice MC, Mehran R; WIN-TAVI Investigators.

Am J Cardiol. 2018 Dec 1;122(11):1909-1916. doi: 10.1016/j.amjcard.2018.08.036. Epub 2018 Sep 8.

PMID:
30318417
28.

How to manage chronic total occlusions in the setting of acute myocardial infarction complicated by cardiogenic shock?

Claessen BE, Mehran R.

Catheter Cardiovasc Interv. 2018 Sep 1;92(3):464-465. doi: 10.1002/ccd.27810.

PMID:
30312996
29.

Determinants of Significant Out-Of-Hospital Bleeding in Patients Undergoing Percutaneous Coronary Intervention.

Sorrentino S, Baber U, Claessen BE, Camaj A, Vogel B, Sartori S, Guedeney P, Chandrasekhar J, Farhan S, Barman N, Sweeny J, Giustino G, Dangas G, Kini A, Sharma S, Mehran R.

Thromb Haemost. 2018 Nov;118(11):1997-2005. doi: 10.1055/s-0038-1673687. Epub 2018 Oct 12.

PMID:
30312975
30.

Paclitaxel-eluting balloon versus everolimus-eluting stent in patients with diabetes mellitus and in-stent restenosis: Insights from the randomized DARE trial.

Claessen BE, Henriques JPS, Vendrik J, Boerlage-van Dijk K, van der Schaaf RJ, Meuwissen M, van Royen N, Gosselink ATM, van Wely MH, Dirkali A, Arkenbout EK, Piek JJ, Baan J Jr.

Catheter Cardiovasc Interv. 2019 Feb 1;93(2):216-221. doi: 10.1002/ccd.27814. Epub 2018 Sep 19.

PMID:
30232824
31.

The quest for the optimal treatment for in-stent restenosis.

Claessen BE, Dangas GD.

Catheter Cardiovasc Interv. 2018 Aug 1;92(2):300-301. doi: 10.1002/ccd.27777. No abstract available.

PMID:
30230205
32.

Meta-Analysis Comparing Complete or Culprit Only Revascularization in Patients With Multivessel Disease Presenting With Cardiogenic Shock.

Bertaina M, Ferraro I, Omedè P, Conrotto F, Saint-Hilary G, Cavender MA, Claessen BE, Henriques JPS, Frea S, Usmiani T, Grosso Marra W, Pennone M, Moretti C, D'Amico M, D'Ascenzo F.

Am J Cardiol. 2018 Nov 15;122(10):1661-1669. doi: 10.1016/j.amjcard.2018.08.003. Epub 2018 Aug 22.

PMID:
30220420
33.

CTCA for detection of significant coronary artery disease in routine TAVI work-up : A systematic review and meta-analysis.

van den Boogert TPW, Vendrik J, Claessen BEPM, Baan J, Beijk MA, Limpens J, Boekholdt SAM, Hoek R, Planken RN, Henriques JP.

Neth Heart J. 2018 Dec;26(12):591-599. doi: 10.1007/s12471-018-1149-6. Review.

34.

The effect of revascularization of a chronic total coronary occlusion on electrocardiographic variables. A sub-study of the EXPLORE trial.

van Dongen IM, Kolk MZH, Elias J, Meijborg VMF, Coronel R, de Bakker JMT, Claessen BEPM, Delewi R, Ouweneel DM, Scheunhage EM, van der Schaaf RJ, Suttorp MJ, Bax M, Marques KM, Postema PG, Wilde AAM, Henriques JPS.

J Electrocardiol. 2018 Sep - Oct;51(5):906-912. doi: 10.1016/j.jelectrocard.2018.07.012. Epub 2018 Jul 19.

35.

Impact of collateralisation to a concomitant chronic total occlusion in patients with ST-elevation myocardial infarction: a subanalysis of the EXPLORE randomised controlled trial.

van Dongen IM, Elias J, van Houwelingen KG, Agostoni P, Claessen BEPM, Hoebers LP, Ouweneel DM, Scheunhage EM, Delewi R, Piek JJ, Råmunddal T, Laanmets P, Eriksen E, Bax M, Suttorp MJ, van der Schaaf RJ, Tijssen JGP, Henriques JPS.

Open Heart. 2018 Jul 16;5(2):e000810. doi: 10.1136/openhrt-2018-000810. eCollection 2018.

37.

Acute myocardial infarction, chronic total occlusion, and cardiogenic shock: the ultimate triple threat.

Claessen BE, Henriques JPS.

EuroIntervention. 2018 Jun 8;14(3):e252-e254. doi: 10.4244/EIJV14I3A42. No abstract available.

38.

Evaluation of the Impact of a Chronic Total Coronary Occlusion on Ventricular Arrhythmias and Long-Term Mortality in Patients With Ischemic Cardiomyopathy and an Implantable Cardioverter-Defibrillator (the eCTOpy-in-ICD Study).

van Dongen IM, Yilmaz D, Elias J, Claessen BEPM, Delewi R, Knops RE, Wilde AAM, van Erven L, Schalij MJ, Henriques JPS.

J Am Heart Assoc. 2018 May 2;7(10). pii: e008609. doi: 10.1161/JAHA.118.008609.

39.

Patient delay in women with STEMI: Time to raise awareness.

Claessen BE, Henriques JPS.

Int J Cardiol. 2018 Jul 1;262:30-31. doi: 10.1016/j.ijcard.2018.03.080. No abstract available.

PMID:
29706392
40.

Incidence, determinants and clinical impact of definite stent thrombosis on mortality in women: From the WIN-DES collaborative patient-level pooled analysis.

Kerkmeijer LS, Claessen BE, Baber U, Sartori S, Chandrasekhar J, Stefanini GG, Stone GW, Steg PG, Chieffo A, Weisz G, Windecker S, Mikhail GW, Kastrati A, Morice MC, Dangas GD, de Winter RJ, Mehran R.

Int J Cardiol. 2018 Jul 15;263:24-28. doi: 10.1016/j.ijcard.2018.04.047. Epub 2018 Apr 12.

PMID:
29691071
41.

Collateral Quality Decay Several Days After Primary Percutaneous Coronary Intervention: A Unique Observation From the EXPLORE Trial.

van Dongen IM, Elias J, van Houwelingen G, Agostoni P, Hoebers LP, Ouweneel DM, Delewi R, Claessen BEPM, van der Schaaf RJ, Henriques JPS; EXPLORE investigators.

JACC Cardiovasc Interv. 2018 Mar 12;11(5):511-512. doi: 10.1016/j.jcin.2017.11.033. No abstract available.

42.

Reply: Paclitaxel-Eluting Balloons or Everolimus-Eluting Stents for In-Stent Restenosis.

Claessen BEPM, Baan J Jr, Henriques JPS.

JACC Cardiovasc Interv. 2018 Mar 12;11(5):506-507. doi: 10.1016/j.jcin.2018.01.231. No abstract available.

43.

Revascularization Strategies in Cardiogenic Shock Patients With MVD: For Now, Keep it Simple.

Henriques JPS, Claessen BE.

J Am Coll Cardiol. 2018 Feb 27;71(8):857-859. doi: 10.1016/j.jacc.2017.12.026. No abstract available.

44.

Long-term impact of chronic total occlusion recanalisation in patients with ST-elevation myocardial infarction.

Elias J, van Dongen IM, Råmunddal T, Laanmets P, Eriksen E, Meuwissen M, Michels HR, Bax M, Ioanes D, Suttorp MJ, Strauss BH, Barbato E, Marques KM, Claessen BEPM, Hirsch A, van der Schaaf RJ, Tijssen JGP, Henriques JPS, Hoebers LP; EXPLORE investigators.

Heart. 2018 Sep;104(17):1432-1438. doi: 10.1136/heartjnl-2017-312698. Epub 2018 Feb 20.

PMID:
29463612
45.

A Randomized Comparison of Paclitaxel-Eluting Balloon Versus Everolimus-Eluting Stent for the Treatment of Any In-Stent Restenosis: The DARE Trial.

Baan J Jr, Claessen BE, Dijk KB, Vendrik J, van der Schaaf RJ, Meuwissen M, van Royen N, Gosselink ATM, van Wely MH, Dirkali A, Arkenbout EK, de Winter RJ, Koch KT, Sjauw KD, Beijk MA, Vis MM, Wykrzykowska JJ, Piek JJ, Tijssen JGP, Henriques JPS.

JACC Cardiovasc Interv. 2018 Feb 12;11(3):275-283. doi: 10.1016/j.jcin.2017.10.024. Epub 2017 Nov 7.

46.

Long-term outcomes of a Caucasian cohort presenting with acute coronary syndrome and/or out-of-hospital cardiac arrest caused by coronary spasm.

Vlastra W, Piek M, van Lavieren MA, Hassell MEJC, Claessen BE, Wijntjens GW, van de Hoef TP, Sjauw KD, Beijk MA, Delewi R, Piek JJ.

Neth Heart J. 2018 Jan;26(1):26-33. doi: 10.1007/s12471-017-1065-1.

47.

Culprit Vessel-Only Versus Multivessel Percutaneous Coronary Intervention in Patients With Cardiogenic Shock Complicating ST-Segment-Elevation Myocardial Infarction: A Collaborative Meta-Analysis.

Kolte D, Sardar P, Khera S, Zeymer U, Thiele H, Hochadel M, Radovanovic D, Erne P, Hambraeus K, James S, Claessen BE, Henriques JPS, Mylotte D, Garot P, Aronow WS, Owan T, Jain D, Panza JA, Frishman WH, Fonarow GC, Bhatt DL, Aronow HD, Abbott JD.

Circ Cardiovasc Interv. 2017 Nov;10(11). pii: e005582. doi: 10.1161/CIRCINTERVENTIONS.117.005582. Review.

48.

Efficacy of the RADPAD Protection Drape in Reducing Operators' Radiation Exposure in the Catheterization Laboratory: A Sham-Controlled Randomized Trial.

Vlastra W, Delewi R, Sjauw KD, Beijk MA, Claessen BE, Streekstra GJ, Bekker RJ, van Hattum JC, Wykrzykowska JJ, Vis MM, Koch KT, de Winter RJ, Piek JJ, Henriques JPS.

Circ Cardiovasc Interv. 2017 Nov;10(11). pii: e006058. doi: 10.1161/CIRCINTERVENTIONS.117.006058.

PMID:
29089313
49.

Improved recovery of regional left ventricular function after PCI of chronic total occlusion in STEMI patients: a cardiovascular magnetic resonance study of the randomized controlled EXPLORE trial.

Elias J, van Dongen IM, Hoebers LP, Ouweneel DM, Claessen BEPM, Råmunddal T, Laanmets P, Eriksen E, van der Schaaf RJ, Ioanes D, Nijveldt R, Tijssen JG, Hirsch A, Henriques JPS; EXPLORE investigators.

J Cardiovasc Magn Reson. 2017 Jul 19;19(1):53. doi: 10.1186/s12968-017-0369-z.

50.

Recurrent myocardial infarction in a 47-year-old woman with a mechanical mitral valve prosthesis: Atherosclerosis, embolism, or spasm?

Claessen BE, van den Boogert TPW, Piek JJ.

Catheter Cardiovasc Interv. 2018 Feb 1;91(2):267-270. doi: 10.1002/ccd.27186. Epub 2017 Jul 12.

PMID:
28699262

Supplemental Content

Loading ...
Support Center